Alpha Cognition is trading 10.24% up at $9.80, likely supported by B. Riley initiating coverage at Buy with a $21 price target.
- Continued enthusiasm follows strong second-quarter ZUNVEYL results.
- H.C. Wainwright raised its target to $20 after revenue reached approximately $6.0 million, up 71% sequentially.
- The broader biotech sector is down 2.47%, so sector sentiment is not driving the gain. No trading-volume data was provided.